2ONE Labs Wins Preliminary Injunction in Trademark Dispute

Jan.03

2ONE Labs and Performance Plus Marketing pay $1M bond for preliminary injunction in trademark dispute with ZONE.

According to Ein Presswire on January 2, the American nicotine pouch brand 2ONE Labs and distributor Performance Plus Marketing have paid a $1 million bond to the court in order to secure a preliminary injunction in their trademark dispute with the tobacco brand ZONE.

Vincent Schuman, CEO of 2ONE Labs, emphasized that...

The deposit reflects our commitment to protecting the intellectual property of 2ONE, ensuring the brand's unrestricted expansion in the market without any hindrance from trademark infringers.

Vincent pointed out that the guarantee was made in accordance with a court order and is a crucial step in protecting the company's brand. It is intended to cover any potential losses that may occur if the injunction is overturned. Such legal requirements are common in trademark disputes, and the guarantee amount is much lower than the $50 million initially proposed by Imperial.

2ONE Labs and Performance Plus Marketing remain optimistic during this litigation phase, anticipating a favorable outcome to protect 2ONE's extensive trademark rights in the nicotine pouch product field.

On December 23rd, the American nicotine pouch brand 2ONE Labs announced on its official website that the brand had obtained a favorable preliminary injunction (PI) ruling in a trademark dispute with distributor Performance Plus Marketing over the Empire Tobacco brand ZONE. According to a court order dated December 20, 2024, ZONE nicotine pouches are prohibited from being shipped to trade partners in the United States. (Related reading: 2ONE wins preliminary injunction, Empire Tobacco's ZONE nicotine pouch sales in the U.S. restricted)

References:

[1] [Corrected Release] 2ONE® Secures Preliminary Injunction Bond in Trademark Dispute Against Imperial's Zone Products

Also Read:

[1] 2ONE Labs Prevails in Trademark Dispute against IMB Zone Brand

[2] 2ONE Labs Announces PMTA Submission Update, Nicotine Pouch Products Receive FDA 'Acceptance' Again

[3] U.S. nicotine pouch brand 2ONE Labs says 2ONE® gains FDA “approval”

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Swedish Match to Revamp ZYN Lineup, Discontinue Four Nicotine Pouch Products in 2026

According to Swedish Match’s website, the company plans to discontinue four ZYN nicotine pouch products in 2026, spanning different flavors and strength variants, and is directing consumers to existing substitute options.

Dec.19 by 2FIRSTS.ai

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Novosibirsk Governor: Targeted Vape Restrictions More Effective Than Full Ban

Novosibirsk Region Governor Andrey Travnikov said during a live Q&A session that local authorities have no plans to impose a full ban on the sale of vapes and disposable e-cigarettes. He argued that a regional ban would be ineffective and could encourage gray market activity and cross-border resale.

Dec.12 by 2FIRSTS.ai

Lithuanian Schools Install Vape Detectors as Teen Vaping Surges

Over 30 Lithuanian schools have installed smart vape detectors to curb rising teen e-cigarette use. WHO data show Lithuania ranks worst among 44 countries, with 60% of 15-year-olds having tried vaping. The system alerts staff to smoke and noise changes, helping schools reduce on-campus vaping cases.